EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)

被引：337

作者：

Arendrup, Maiken C. ^{[1
]}

Cuenca-Estrella, Manuel ^{[2
]}

Lass-Floerl, Cornelia ^{[3
]}

Hope, William ^{[4
]}

机构：

[1] Statens Serum Inst, Dept Microbiol Surveillance & Res, Unit Mycol, DK-2300 Copenhagen, Denmark

[2] Natl Ctr Microbiol, Inst Salud Carlos III, Mycol Reference Lab, Majadahonda, Spain

[3] Innsbruck Med Univ, Div Hyg & Microbiol, Innsbruck, Austria

[4] Univ Manchester, Univ Hosp S Manchester NHS Fdn Trust, Translat Res Facil Resp Med, NIHR,Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2012年 / 18卷 / 07期

关键词：

antifungals; Candida; Cryptococcus; EUCAST; minimum inhibitory concentration; susceptibility testing; yeast; AMPHOTERICIN-B; SUSCEPTIBILITY;

D O I：

10.1111/j.1469-0691.2012.03880.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Clin Microbiol Infect 2012; 18: E246E247 Abstract The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) has revised the EDef 7.1 document on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for fermentative yeasts. Changes are: dimethylsulphoxide is now the recommended solvent for caspofungin, micafungin and fluconazole; the shelf-life of plates containing the echinocandins prepared from stock solutions in dimethylsulphoxide is extended to 6 months at -80 degrees C; testing of amphotericin and Cryptococcus has been incorporated; and minimum inhibitory concentration ranges for quality control strains and anidulafungin are included.

引用

页码：E246 / E247

页数：2

共 8 条

[1] Echinocandin Susceptibility Testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 Standard Procedures: Analysis of the Influence of Bovine Serum Albumin Supplementation, Storage Time, and Drug Lots
Arendrup, Maiken Cavling
Rodriguez-Tudela, Juan-Luis
Park, Steven
Garcia-Effron, Guillermo
Delmas, Guillaume
Cuenca-Estrella, Manuel
Gomez-Lopez, Alicia
Perlin, David S.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (04) : 1580 - 1587
[2] Detection of resistance to amphotericin B in Candida isolates by using Iso-Sensitest broth
Cuenca-Estrella, M
Díaz-Guerra, TM
Mellado, E
Rodríguez-Tudela, JL
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) : 2070 - 2074
[3] Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin B
LozanoChiu, M
Nelson, PW
Lancaster, M
Pfaller, MA
Rex, JH
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (01) : 270 - 272
[4] DETECTION OF AMPHOTERICIN B-RESISTANT CANDIDA ISOLATES IN A BROTH-BASED SYSTEM
REX, JH
COOPER, CR
MERZ, WG
GALGIANI, JN
ANAISSIE, EJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (04) : 906 - 909
[5] EUCAST Definitive Document EDef 7.1:: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts
Rodriguez-Tudela, J. L.
Arendrup, M. C.
Barchiesi, F.
Bille, J.
Chryssanthou, E.
Cuenca-Estrella, M.
Dannaoui, E.
Denning, D. W.
Donnelly, J. P.
Dromer, F.
Fegeler, W.
Lass-Floerl, C.
Moore, C.
Richardson, M.
Sandven, P.
Velegraki, A.
Verweij, P.
[J]. CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (04) : 398 - 405
[6] Rodríguez-Tudela JL, 2003, CLIN MICROBIOL INFEC, V9
[7] COMPARISON OF ETEST AND NATIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS BROTH MACRODILUTION METHOD FOR ANTIFUNGAL SUSCEPTIBILITY TESTING - ENHANCED ABILITY TO DETECT AMPHOTERICIN B-RESISTANT CANDIDA ISOLATES
WANGER, A
MILLS, K
NELSON, PW
REX, JH
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) : 2520 - 2522
[8] Process Analysis of Variables for Standardization of Antifungal Susceptibility Testing of Nonfermentative Yeasts
Zaragoza, Oscar
Mesa-Arango, Ana C.
Gomez-Lopez, Alicia
Bernal-Martinez, Leticia
Rodriguez-Tudela, Juan Luis
Cuenca-Estrella, Manuel
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (04) : 1563 - 1570

← 1 →